F. Sempere, Mari Luz Moreno Sancho, E. Drehmer, Bárbara Gómez, Sandra Carrera Juliá, Marí Ángeles Navarro, M. J. Vega
{"title":"费伦-麦克德米德综合征:西班牙一种罕见疾病的流行","authors":"F. Sempere, Mari Luz Moreno Sancho, E. Drehmer, Bárbara Gómez, Sandra Carrera Juliá, Marí Ángeles Navarro, M. J. Vega","doi":"10.3390/mol2net-07-11835","DOIUrl":null,"url":null,"abstract":"Graphical Abstract Abstract. Phelan-McDermid Syndrome (PMS) is a rare genetic condition caused by a deletion of the terminal end of chromosome 22 in the 13.3 region, as well as, by point mutations within SHANK3 gene. The most characteristic clinical symptom is global developmental delay, absent or severely delayed speech, hypotonia and autism spectrum disorder. The syndrome is underdiagnosed and its real incidence remains unknown, but more than 2,000 cases have been reported worldwide. In the present investigation patients diagnosed with PMS for twelve years were recruited","PeriodicalId":136053,"journal":{"name":"Proceedings of MOL2NET'21, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 7th ed.","volume":"53 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phelan-McDermid Syndrome: The prevalence of a rare disease in Spain\",\"authors\":\"F. Sempere, Mari Luz Moreno Sancho, E. Drehmer, Bárbara Gómez, Sandra Carrera Juliá, Marí Ángeles Navarro, M. J. Vega\",\"doi\":\"10.3390/mol2net-07-11835\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Graphical Abstract Abstract. Phelan-McDermid Syndrome (PMS) is a rare genetic condition caused by a deletion of the terminal end of chromosome 22 in the 13.3 region, as well as, by point mutations within SHANK3 gene. The most characteristic clinical symptom is global developmental delay, absent or severely delayed speech, hypotonia and autism spectrum disorder. The syndrome is underdiagnosed and its real incidence remains unknown, but more than 2,000 cases have been reported worldwide. In the present investigation patients diagnosed with PMS for twelve years were recruited\",\"PeriodicalId\":136053,\"journal\":{\"name\":\"Proceedings of MOL2NET'21, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 7th ed.\",\"volume\":\"53 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of MOL2NET'21, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 7th ed.\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/mol2net-07-11835\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of MOL2NET'21, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 7th ed.","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/mol2net-07-11835","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Phelan-McDermid Syndrome: The prevalence of a rare disease in Spain
Graphical Abstract Abstract. Phelan-McDermid Syndrome (PMS) is a rare genetic condition caused by a deletion of the terminal end of chromosome 22 in the 13.3 region, as well as, by point mutations within SHANK3 gene. The most characteristic clinical symptom is global developmental delay, absent or severely delayed speech, hypotonia and autism spectrum disorder. The syndrome is underdiagnosed and its real incidence remains unknown, but more than 2,000 cases have been reported worldwide. In the present investigation patients diagnosed with PMS for twelve years were recruited